ReviewCurrent pain and headache reports2026
An Individualized, Interdisciplinary Approach to the Perioperative Care of Patients on Buprenorphine.
Review in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewThis review provides an overview of the pharmacodynamics and pharmacokinetics of buprenorphine followed by a review of the published research on the perioperative use of buprenorphine for acute postoperative pain, and analgesia management in patients already on buprenorphine. RECENT
findingsCurrent evidence comparing buprenorphine with full opioid agonists is heterogeneous, showing either modest superiority or comparable analgesic efficacy, with a reduced incidence of certain adverse effects such as respiratory depression. Despite concerns that its high receptor affinity may limit the efficacy of additional opioids, buprenorphine can be safely combined with other opioid agonists for breakthrough and perioperative pain. Perioperative management requires an individualized, interdisciplinary approach, taking into account patient-specific risk factors. Multimodal analgesia-including regional techniques, non-opioid medications, adjunctive agents, and nonpharmacological strategies-forms the cornerstone of effective perioperative pain control. A structured postoperative plan with dose adjustment, coordinated follow-up, and collaboration with outpatient prescribers is critical. Early involvement of the Acute Pain Services team could be beneficial.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.